ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Biomarkers"

  • Abstract Number: 2159 • 2014 ACR/ARHP Annual Meeting

    Human T-Lymphotropic Virus Type 1 Biomarkers in Patients with Rheumatoid Arthritis

    Akihiko Okayama1, Masako Iwanaga2, Yasuko Sagara3, Toshihiko Hidaka4, Kunihiko Umekita5, Kazumi Nakano6, Toshiki Watanabe6, Yoshihisa Yamano7, Yoshiro Horai8, Hideki Nakamura9 and Atsushi Kawakami9, 1Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki, Japan, 2The Jikei University of School of Medicine, Tokyo, Japan, 3Japanese Red Cross Kyushu Block Blood Center, Fukuoka, Japan, 4Zenjinkai Shimin-No-Mori Hospital, Miyazaki, Japan, 5University of Miyazaki, Miyazaki, Japan, 6Laboratory of Tumor Cell Biology, Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan, 7Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa, Japan, 8Departments of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 9Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    Background/Purpose: Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia (ATL). It has been debated recently whether or not immunosuppressive…
  • Abstract Number: 1632 • 2014 ACR/ARHP Annual Meeting

    Is Liopxin A4 a Biomarker for Systemic Lupus Erythematosus?

    Manal Sedky Abdou1, Dina Effat2, Lamiaa Mansour3, Mona mohsen Abdul Salam3 and Noha abd El Baky4, 1rheumatology and rehabilitation kasr el aini hospital, faculty of medicin, cairo university, cairo, Egypt, 2rheumatology and rehabilitation, faculty of medicin, cairo university, giza, Egypt, 3clinical and chemical pathology, faculty of medicin, cairo university, cairo, Egypt, 4rheumatology and rehabilitation, faculty of medicin, cairo university, cairo, Egypt

    Background/Purpose : Systemic lupus erythematosus (SLE) is characterized by autoantibody production and immune complex deposition which trigger both a local and systemic inflammatory response. The…
  • Abstract Number: 1138 • 2014 ACR/ARHP Annual Meeting

    Vasoactive Intestinal Peptide (VIP) Genetic Variants Determine VIP Serum Levels and Could be Used As a Prognosis Biomarker

    Amalia Lamana1, Iria Valino-Seoane2, Luis Rodriguez-Rodriguez3, Javier Leceta2, Yasmina Juarranz2, Ana M. Ortiz Garcia1, Carmen Martinez-Mora4, Benjamín Fernández-Gutiérrez3, Isidoro González-Alvaro5, Rosa P Gomariz2 and Rosario Garcia-Vicuña5, 1Rheumatology, Hospital Universitario de La Princesa. IIS Princesa, Madrid, Spain, 2Cellular Biology, School of Biology. Universidad Complutense de Madrid, Madrid, Spain, 3Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 4Cellular Biology, School of Medicine. Universidad Complutense de Madrid, Madrid, Spain, 5Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain

    Background/Purpose: VIP has shown immunoregulatory properties in assays performed with human or murine cells. VIP has demonstrated a therapeutic effect in a murine model of…
  • Abstract Number: 629 • 2014 ACR/ARHP Annual Meeting

    Biomarkers of Chondrocyte Activity Are Increased in Psoriasis Arthritis and Spondyloarthritis

    Natasja Stæhr Gudman1, Heidi Lausten Munk2, Anne Friesgaard Christensen3, Leif Ejstrup4, Grith Lykke Sørensen5, Anne Gitte Loft3, Morten A. Karsdal6, Anne C. Bay-Jensen7, Yi He8, Anne Sofie Siebuhr9 and Peter Junker2, 1Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 2Department of Rheumatology, Odense University Hospital, Odense, Denmark, 3Department of Rheumatology, Vejle Hospital, Vejle, Denmark, 4Department of Rheumatology, Esbjerg Hospital, Esbjerg, Denmark, 5Cardiovascular and Renal Research, Institute of Molecular Medicin, University of Southern Denmark, Odense, Denmark, 6Research & Development, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 7Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 8Nordic Bioscience, Herlev, Denmark, 9Rheumatology, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark

    Background/Purpose: Psoriasis arthritis (PsA) and spondyloarthritis (SpA) are both inflammatory joint diseases in which the pathogenesis is not fully understood. However, both pathologies are associated…
  • Abstract Number: 222 • 2014 ACR/ARHP Annual Meeting

    OA Phenotypes Rather Than Disease Stage Drive Structural Progression – Identification of Structural Progressors from 2 Phase III Randomized Clinical studies with Symptomatic Knee OA

    Morten Asser Karsdal1, Anne C. Bay-Jensen2, Asger Bihlet3, Peter Alexandersen4, Inger Byrjalsen3, Bente J. Riis3 and Claus Christiansen3, 1Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 2Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 3Nordic Bioscience, Herlev, Denmark, 4Center for Clinical and Basic Research, Vejle, Denmark

    Background/Purpose: Osteoarthritis (OA) is a heterogeneous disorder, with several possible drivers of disease progression. Up to 50% of OA patients do not structurally progress, emphasizing…
  • Abstract Number: 2147 • 2014 ACR/ARHP Annual Meeting

    Automatically Extracted Quantitative Biomarkers for Assessing Connective Tissue Disease Using Nailfold Capillaroscopy

    Michael Berks1, Graham Dinsdale2, Andrea Murray2, Tonia Moore3, Chris Taylor1 and Ariane Herrick2, 1Centre for Imaging Sciences, University of Manchester, Institute of Population Health, Manchester, United Kingdom, 2Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, 3Salford Royal Hospital NHS Foundation Trust, Salford, United Kingdom

    Background/Purpose Videomicroscopy can capture high-magnification images of nailfold capillaries, allowing non-invasive assessment of microvasculature change indicative of connective tissue disease. Whilst images may be qualitatively…
  • Abstract Number: 1631 • 2014 ACR/ARHP Annual Meeting

    Cell Bound Complement Activation Products and Their Relationship to Disease Activity and Quality of Life Measures in Systemic Lupus Erythematosus

    Richard Furie1, Jill P. Buyon2, R. Ramsey-Goldman3, Chaim Putterman4, Kenneth Kalunian5, Tyler O'Malley6, John Conklin7, Derren Barken8 and Thierry Dervieux9, 1Division of Rheumatology, North Shore-LIJ Health System, Great Neck, NY, 2Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 3Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 4The Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 5UCSD School of Medicine, La Jolla, CA, 6Research and Development, Exagen Diagnostics, Inc., Vista, CA, 71261 Liberty Way Suite C, Exagen Diagnostics, Inc., Vista, CA, 8Exagen Diagnostics, Inc., Vista, CA, 9rd, Exagen Diagnostics, Inc., Vista, CA

    Background/Purpose: To assess the association between cell bound complement activation products (CBCAPS) and measures of disease activity and quality of life in systemic lupus erythematosus…
  • Abstract Number: 1135 • 2014 ACR/ARHP Annual Meeting

    Genes Involved in Cartilage Synthesis and Risk to Knee Osteoarthritis

    Abhishek Mishra Sr., Rajeshwar Srivastava II, Divya Sanghi III, Ajai Singh IV and Devendra Parmar V, Deptt of Orthopaedic Surgery, King George's Medical University,, Lucknow, India

    Background/Purpose  Osteoarthritis (OA), characterized by gradual loss of articular cartilage in the joint, is a leading cause of disability among the elderly people. Though the…
  • Abstract Number: 628 • 2014 ACR/ARHP Annual Meeting

    The Predictive Value of Cardiovascular and Metabolic Biomarkers for Progression of Atherosclerosis in Psoriatic Disease

    Lihi Eder1, Fatima Abji1, Cheryl Rosen2, Vinod Chandran1 and Dafna D. Gladman1, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Dermatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose The pathophysiologic mechanisms underlying the accelerated atherosclerosis in patients with psoriatic disease (PsD) are unknown. We aimed to investigate candidate pathways involved in this…
  • Abstract Number: 137 • 2014 ACR/ARHP Annual Meeting

    Evaluation of Metalloproteinase-3 As a Soluble Biomarker of Synovitis Using Weighted Joint Counts Assessed Clinically and on Ultrasound Imaging

    Agata Burska1,2, Elizabeth Hensor2,3, Jackie L. Nam3, Lukasz Kozera4, Richard J. Wakefield3, Paul Emery3 and Ann W Morgan5, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds., Leeds, United Kingdom, 2joint first authorship, Leeds, United Kingdom, 3NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 4Faculty of Pharmacy and Laboratory Diagnostics, Wroclaw Medical University, Wroclaw, Poland, Wroclaw, Poland, 5NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Synovial inflammation is known to play a central role in articular cartilage degradation in rheumatoid arthritis (RA); it could be a passive marker of…
  • Abstract Number: 2862 • 2013 ACR/ARHP Annual Meeting

    Autoantigen Microarray Analysis Of Sera From New-Onset Pediatric Systemic Lupus Erythematosus Patients: A Distinct Autoantibody Profile Associated With Class III/IV Lupus Nephritis

    Imelda Balboni1, David Haddon2, Vivian Diep2, Cindy Limb2 and Paul Utz2, 1Pediatrics, Stanford University School of Medicine, Palo Alto, CA, 2Medicine, Stanford University School of Medicine, Stanford, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous systemic autoimmune disease characterized by the production of autoantibodies directed against highly-conserved nuclear antigens. 15-20% of SLE…
  • Abstract Number: 2189 • 2013 ACR/ARHP Annual Meeting

    TLR 4 Endogenous Ligand MRP8/14 Levels in Enthesitis Related Arthritis (ERA) and Its Association With Disease Activity and TLR 4 Expression

    Amita Aggarwal1, Mujeeb Rahman1, Arpita Myles2, Priyanka Gaur2 and Ramnath Misra1, 1Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Background/Purpose: Enthesitis related arthritis (ERA) is an inflammatory disease of childhood that lacks autoreactive T and B cells. We have previously shown that surface expressed…
  • Abstract Number: 1716 • 2013 ACR/ARHP Annual Meeting

    Childhood-Onset Systemic Lupus Erythematosus With Clinical Neurocognitive Dysfunction Have Lower Nodal Density and Connectivity On Diffusion Tensor Imaging

    Jordan T. Jones1, Mark DiFrancesco2, Ahmad I. Zaal1, Marisa S. Klein-Gitelman3, Darren Gitelman4, Jun Ying5 and Hermine Brunner1, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Division of Rheumatology, Children's Memorial Hospital, Chicago, IL, 4Neurology, Northwestern University, Chicago, IL, 5Medicine-Internal Medicine-General Medicine, University of Cincinnati, Cincinnati, OH

    Background/Purpose: Neurocognitive dysfunction (NCD) is common in childhood-onset systemic lupus erythematosus (cSLE), and often difficult to detect with current resources.  Diffusion tensor imaging (DTI) is…
  • Abstract Number: 879 • 2013 ACR/ARHP Annual Meeting

    Serological Biomarkers Of Specific Mode Of Action For Early Identification Of Rheumatoid Arthritis Patients Who Respond To Anti-IL6 Or Anti-TNF Treatment

    Anne C. Bay-Jensen1, Natasja Stæhr Gudman2, Anne Sofie Siebuhr1, Claus Christiansen3 and Morten Asser Karsdal2, 1Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 2Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 3Nordic Bioscience, Herlev, Denmark

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized debilitating joint destruction, if not treated aggressively in the patient in most need of treatment. …
  • Abstract Number: L19 • 2013 ACR/ARHP Annual Meeting

    Kellgren-Lawrence Grade (KL) 0 Vs. KL 1 Knees Differ in Their MRI Predictors of Subsequent Radiographic Osteoarthritis

    C.Kent Kwoh1, Ali Guermazi2, Tomoko Fujii3, Robert M. Boudreau3, Michael Hannon4, Jason Grago4, David Hunter5, Felix Eckstein6 and Frank Roemer7, 1Department of Medicine, The University of Arizona Arthritis Center, Tucson, AZ, 2Radiology, Boston University School of Medicine, Boston, MA, 3Epidemiology, University of Pittsburgh, Pittsburgh, PA, 4Medicine, University of Pittsburgh, Pittsburgh, PA, 5University of Sydney, Sydney, Australia, 6Paracelsus Medical University, Salzburg, Austria, 7Klinikum Augsburg, Augsburg, Germany

    Background/Purpose: Kellgren-Lawrence grade (KL) 1, defined by a questionable osteophyte and/or doubtful joint space narrowing, is thought to be an intermediate stage from non-OA (i.e.,…
  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 109
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology